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For incident cancers of the cervix uteri (601 cases) registered in the population-based cancer registry of Khon Kaen province,
Northeast Thailand, in 1985–1990 loss-adjusted survival probabilities were estimated by a logistic regression model with four
prognostic factors (age at diagnosis, stage of disease, place of residence and treatment), and compared with observed survival,
estimated by the actuarial method. All patients were followed up for a minimum of 5 years, using both passive and active methods. In
all, 27.6% of patients were lost to follow-up within 5 years of the index date. The overall observed survival at 5 years was 56.8% and
loss-adjusted survival was 54.7%. The difference between the loss-adjusted and observed survival at 5 years was small: 2.1% overall,
varying between 0.8 and 3.5 percent units for any prognostic group. The assumption of independence of loss to follow-up and death
in the calculation of survival by the actuarial method in this, and probably in other, population-based series, is reasonable and leads to
no material bias in the estimates.
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Population level survival is usually estimated by the life-table
method, in which cumulative probability of survival is calculated
at successive annual intervals after diagnosis (Cutler & Ederer,
1958; Ederer et al, 1961). Information from all cases is used,
including cases whose follow-up ends due to closure of the study,
and those lost to follow-up before closure. Survival estimates may
be biased if the proportion of cases lost to follow-up is substantial
(as in many developing countries, where health information
systems are not well developed), and if the loss to follow-up is
correlated with the probability of death (prognosis) of the patient
after he or she was lost.
Prognostic factors that may also predict loss to follow-up are
related to the clinical characteristics of the disease, the patient and
the social environment. For example, recurrence or relapse of the
disease and serious comorbidity are prognostic factors that may
cause the patient to move away (for treatment, or terminal care),
making them impossible to trace. Social status influences the
probability of survival from cancer (Kogevinas and Porta, 1997)
and may also affect the ability to follow-up of a subject.
Information on the association between prognostic factors and
loss to follow-up can be used to reduce the bias in estimates of
survival (Ganesh, 1995; Mathew, 1996). In this paper, we calculate
the absolute survival of cases of cancer of the cervix recorded by a
population-based cancer registry in Thailand, using the actuarial
method, and examine the effect of adjustment for differential loss
to follow-up within subgroups of patients at different risk of death
from the disease (‘loss adjustment’).
SUBJECTS AND METHODS
A total of 630 invasive incident cancers of the cervix were
registered during 1985–1990 in the population-based cancer
registry covering the province of Khon Kaen. Of these, 29 (4.6%)
were registered on the basis of a death certificate only, and were
excluded from the survival analysis. For the remaining 601 cases,
data on age at diagnosis, area (district) of residence, date of
incidence, topography, morphology, stage of disease, treatment
(whether treatment by surgery, radiation or chemotherapy was
recorded in the patient file), date and vital status (alive or dead) at
last contact were abstracted from the registry database.
Patients were followed up until death, or date of loss to follow-
up, or 31 December 1995 (closing date). Therefore, the potential
length of follow-up was 5–10 years. The registry used both passive
and active measures to establish the vital status (alive/dead) of
cancer patients.
Passive follow-up
All death certificates (with a mention of any cancer (ICD-9: 140–
208) as underlying or contributing cause of death) were obtained
from the Provincial Health Department. The death certificates were
linked to the cancer registry database at annual intervals (using
national ID number, name, date of birth and address) and the date
of death updated for matching cases.
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For the remaining unmatched cases, information on follow-up was
collected by visiting the various hospitals to scrutinise case
records, and by making enquiries of treating physicians and
general practitioners. Annual follow-up on the anniversary of the
date of incidence was attempted for presumed survivors by
sending a reply-paid postcard inquiring about the current status of
the patient. If no reply was received, a second postcard was sent to
the headman of the village requesting the same information. House
visits were also performed wherever feasible.
Analytical methods
Actuarial survival The estimation of survival probability for each
year was carried out by the actuarial method. The index date of
this study was the date of incidence. The duration of survival for
each case was calculated as the time elapsed from the index date to
the date of death or the last date of follow-up or closing date,
whichever was earlier. Cumulative absolute survival (Cutler and
Ederer, 1958) was estimated using the SURV3 analysis programme
(Dickman et al, 2002).
Loss-adjusted survival The method proposed by Ganesh (1995)
was used and is described in detail in the statistical appendix.
  Step 1 – Choice of potential confounding (prognostic) factors
(X1,y,X4), and strata (j) for each factor.
Cases were allocated to 64 strata within four factors: (i) age
(four levels: o40, 40–49, 50–59, 60þ), (ii) stage of disease
(four levels: I, II, III and IV, unknown), (iii) cancer-directed
treatment (two levels: yes, no) and (iv) place of residence (two
levels: Muang and surrounding districts, other). Muang district
is in the centre of Khon Kaen province where Khon Kaen city is
located.
  Step 2 – Classification of study subjects into two main
categories: those with complete follow-up and those lost to
follow-up.
At a given survival time (annual), ‘i’¼1–5 (say), the subjects in
each stratum (nij) were classified into two groups: (1) those
‘completely followed up’, denoted by nij
0, comprising those dead
(dij) during the interval (i) or alive (wij) at the end of the annual
interval, and (2) those ‘lost to follow-up’, denoted by li), who
were last known to be alive in the annual interval and status
unknown thereafter.
  Step 3 – Computation of probability of death (qij
0) for all i and j
for factors X1,y,X4 among cases with complete follow-up
(nij
0 ¼nij li ).
The probability of death (qij
0) at each annual interval i, was
estimated by means of a logistic regression model, using cases
with complete follow-up only (nij
0), with all factors (j) taken into
account simultaneously in the model. Stata version 7.0 (2001)
software was used to estimate the regression coefficients.
  Step 4 – Computation of expected deaths (dij
0) among cases lost
to follow-up (lij).
The expected deaths (dij
0) among the group of cases lost to
follow-up (lij) were estimated by assigning the same probability
(qij
0) of death.
  Step 5 – Computing the loss-adjusted survival for each interval i.
The computation of the conditional probability of dying (qi),
conditional probability of surviving (pi) and the cumulative
probability (Pi) of surviving the current and subsequent annual
intervals of time are estimated by accumulating the numbers dij,
dij
0, nij, nij
0 over the confounders, j, and proceeding under the
modified actuarial framework of generating life table, as
described in the statistical appendix.
RESULTS
A total of 601 (95.4%) out of 630 cases of cancer of the cervix
diagnosed during 1985–1990 were included in the survival study;
all patients were followed to the end of 1995 or later. In all, 83%
were diagnosed microscopically. Table 1 shows the distribution of
cases by age, stage, treatment received and place of residence. In
Table 1 Number of cases, proportion and risk (odds ratio, OR) of death and loss to follow-up at 5 years from the index date and 95% confidence interval
(CI) by factors studied
Proportion at 5 years from index date Odds ratio (OR) and 95% CI
Factors studied Number of cases Lost (%) Dead (%) Lost OR
a Dead
b OR
a
All cases 601 27.6 36.4
(1) Age group
o40 122 27.9 24.6 1.0 1.0
40–49 194 24.2 35.1 0.9 (0.5–1.5) 1.5 (0.8–2.7)
50–59 158 29.1 36.7 1.2 (0.7–2.0) 2.0 (1.1–3.7)
60+ 127 29.9 49.6 1.2 (0.7–2.1) 3.5 (1.8–6.9)
(2) Stage of diseases
Stage I 93 23.7 20.4 1.0 1.0
Stage II 134 28.4 29.1 1.2 (0.7–2.2) 1.8 (0.9–3.6)
Stage III and IV 222 21.6 53.6 0.8 (0.4–1.5) 5.0 (2.7–9.5)
Stage unknown 152 37.5 27.6 1.4 (0.7–2.6) 1.5 (0.7–3.1)
(3) Treatment
Received treatment 428 22.4 36.2 1.0 1.0
No treatment 173 39.9 37.0 2.0 (1.3–3.1) 2.0 (1.2–3.4)
(4) Residency
Muang and surrounding
Districts 274 28.1 32.9 1.0 1.0
Other districts 327 26.9 39.4 0.8 (0.6–1.2) 1.5 (1.0–2.3)
aORs of each factor adjusted for all other factors in the table.
bEstimated among those with complete follow-up only.
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over 60; 93 cases (15.5%) were stage I, 22.3% stage II, 31.5% stage
III, 5.5% stage IV and 25.3% were of unknown stage at diagnosis. A
total of 45.6% of cases were residents of Muang and surrounding
districts; 71.2% of patients received treatment through either
surgery or radiation or chemotherapy.
Risk of loss to follow-up and death
The proportion and risk (odds ratio) of death and loss to follow-up
at 5 years from the index date, by prognostic factors, are presented
in Table 1. The proportion of patients lost to follow-up during the
5-year period was 27.6%, and of dying was 36.4%. The risk of loss
to follow-up varied 1.3-fold by age at diagnosis, 1.6-fold by stage of
disease and 1.2-fold by place of residence; the risk of loss to follow-
up among cases not treated was two-fold higher than those treated.
The risk of death increased 3.5-fold with increasing age at
diagnosis, and five-fold with stage of disease (Po0.001), with the
highest risk observed in stages III and IV. Those with stage
unknown also had a higher risk of death than those in stage I
(OR¼1.5). Patients with no treatment had a two-fold higher risk
of death and patients who lived far away from the centre of the
province had a 50% higher risk than those who lived nearby.
Survival from cervix cancer (actuarial and loss-adjusted)
The observed (actuarial) survival at 5 years was 56.8% (Table 2).
During this period, 27.6% of cases were lost to follow-up; 13.3% in
the first year, 5.1% of those remaining in the second and third
years, and 19.3% of the remainder in the fourth and fifth years
(Table 2).
Adjustment for loss of follow-up gave an estimated survival of
54.7% at 5 years from index date, 2.1% units less than the observed
(actuarial) survival. This suggests that the patients who were lost to
follow-up had a higher mortality than assumed in the actuarial
method of survival analysis, in which such deaths occur at the
same rate as among those with complete follow-up. Table 2 also
gives the estimate of loss-adjusted survival by age group, stage,
treatment and residence, each adjusted for differential loss to
follow-up by the other three factors.
Age An inverse relationship between survival and age at diagnosis
was evident: Patients aged less than 40 years had the best survival
and patients aged more than 60 years had the poorest survival by
both estimation methods. The degree of bias introduced into the
actuarial estimate by differential loss to follow-up was small, in the
range of 1.2–2.9% units, and the variation by age was somewhat less
than indicated by the actuarial estimates.
Stage of disease Patients with stage I had the best survival
(74.6%) and stage III and IV had the poorest survival (38.2%). The
reduction in the differences of survival between loss-adjusted and
actuarial estimates was the highest in patients with unknown stage
(3.5% units) and the smallest in patients with stage III and IV
disease (0.8% units).
Treatment Patients who received treatment had better survival
(57.5%) than those who had not (47.5%). The reduction in the
differences of survival between loss-adjusted survival and actuarial
estimates was higher in the untreated (2.4% units) than in those
who received treatment (1.7% units).
Place of residence Patients who lived in Muang and surrounding
districts had better survival (58.6%) than patients who lived in
other districts (51.4%). Loss-adjusted survival revealed a reduction
in estimated survival compared with that estimated by the
actuarial method, for both residence groups. The difference in
survival estimates was 2.5% units for residents of Muang and
surrounding districts and 1.8% units for those living in other
districts.
These small changes in the estimate of survival following the
loss-adjustment procedure indicate the presence of a small bias in
Table 2 Number of cases, proportion lost to follow-up at varying intervals of time and 5-year cumulative absolute and loss-adjusted survival of factors
studied
% lost to follow-up among persons at risk of death at
varying lengths of time (i) from index date % Absolute survival
Factors studied No. of cases o1 year 1rio3 years 3rio5 years Actuarial Loss-adjusted
a
All cases 601 13.3 5.1 19.3 56.8 54.7
(1) Age group
o40 122 13.1 4.1 17.9 71.0 68.1
40–49 194 11.3 4.8 16.4 59.7 57.8
50–59 158 13.9 6.6 19.8 55.7 53.4
60+ 127 15.8 4.8 26.9 38.8 37.6
(2) Stage of diseases
Stage I 93 7.5 1.2 19.4 77.1 74.6
Stage II 134 9.7 9.0 18.3 65.5 63.0
Stage III and IV 222 9.0 5.8 20.2 39.0 38.2
Stage unknown 152 26.3 3.2 19.2 63.3 59.8
(3) Treatment
Received
treatment
428 6.8 6.4 17.2 59.2 57.5
No treatment 173 29.5 0.0 27.7 49.9 47.5
(4) Residency
Muang and
surrounding
districts
274 13.1 5.2 19.6 61.1 58.6
Other districts 327 13.5 5.1 19.0 53.2 51.4
aEach factor adjusted for differential loss to follow-up by other factors in the table.
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cases lost to follow-up, than under the actuarial assumption.
DISCUSSION
The fundamental step in carrying out an end result study is to
ensure good and complete follow-up of patients. The actuarial (life
table) method uses information from all subjects, including those
censored before 5 years follow-up or death. Losses to follow-up
and withdrawals may have different effects on the estimates of
survival. The actuarial survival rate gives an unbiased estimate of
true survival only if censorship has the same distribution between
the groups being compared (Hakulinen, 1982) and is independent
of risk of the outcome studied (Ganesh, 1995). The bias in the
estimation of survival probability is dependent on both the
magnitude and nature of losses to follow-up, and may be in either
direction. For example, the true probability of death of patients
lost to follow-up may be greater than assumed if patients with poor
prognosis are more likely to be lost. In these circumstances, the
actuarial survival estimate is biased and too high.
If the vital status of all the cases included in a survival study is
known at the closing date, the estimation of survival probability by
the actuarial method is straightforward and unbiased. In the
present study, all subjects could be potentially followed for at least
5 years, so that there were no withdrawals, and all censoring was
due to loss to follow-up. In developing countries, it is difficult to
obtain complete follow-up information for all patients for various
reasons. Typically, cancer patients no longer being followed up in
hospital must be traced by active methods, involving postal
enquires or home visits. Patients frequently migrate from their
usual place of residence to that of their relatives and the hospital/
medical centre may not be informed of the change in address. This
makes tracing of patients at home difficult, since the new contact
address must be obtained from other sources, neighbours or
friends, for example. Migration is typically related to the
recurrence of the disease, that is, with factors of prognostic
significance; its magnitude depends on the nonrandom nature and
the extent of the loss to follow-up. It is therefore important in any
survival study to ascertain not only the extent of loss to follow-up,
but also its independence of the probability of death.
The first step in deciding whether bias in the actuarial estimate
of survival is likely is to examine whether loss to follow-up varies
according to prognostic variables such as age, stage, residence and
treatment group. Computation of loss-adjusted survival (Ganesh,
1995) then takes into consideration such differential losses, by
assuming that patients lost to follow-up within strata defined by
these variables have the same probability of death as those still
remaining under observation and belonging to the same stratum.
It is reasonable to expect survival experience in patients lost to
follow-up and with complete follow-up to be more similar within a
prognostic group, than when all patients are considered together.
The difference between the crude actuarial survival and the loss-
adjusted value indicates the magnitude of the effect of differential
loss to follow-up.
The small difference between the absolute (actuarial) survival
and the loss-adjusted survival observed in this study is much less
than in other studies (Ganesh, 1995; Mathew, 1996). Large
differences in LAR and actuarial estimates have been found in
hospital-based series of patients, coming from a wide geographic
area, where follow-up of patients no longer attending hospital
clinics by house visits was impractical and no postal enquiries
were made. In contrast, an international comparison of actuarial
and loss-adjusted survival of cervix cancer cases from different
population-based cancer registries in developing countries (Swa-
minathan et al. 2002) found that the maximum difference was
4.1%, with a loss to follow-up of 44% and presence of
nonrandomness. The observation was not confined to cancer of
the cervix; differences for other sites like female breast (data from
six registries from developing countries) and larynx (data from
Chennai and Mumbai cancer registries) were of similar (small)
size. This may be mainly because of the integration of mortality
data collection into the case-finding operations of population-
based cancer registries (on an annual basis in Khon Kaen). It
confirms the finding of the present study, that in a population-
based series the assumption of independency of loss to follow-up
and death was reasonable, so that calculation of survival by the
actuarial method without adjusting for losses to follow-up is likely
to have resulted in no material bias in the estimates. However, this
is not true in general; the experience of hospital-based series in
particular indicates that bias may be considerable, and requires
appropriate adjustment of survival estimates.
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STATISTICAL APPENDIX
Loss-adjusted survival
The procedure for estimating loss-adjusted survival by the stratified
method can be described step by step in the actuarial survival
estimation framework. However, there is also a different approach
which integrates estimation by a regression technique and the life
table approach. It is the latter that is sequentially described here:
In the follow-up interval i in prognostic stratum j, there will be
nij patients alive at the beginning of the interval, of whom dij will
die, wij will be withdrawn alive because of the closing date of
follow-up and lij will be lost to follow-up during the interval.
Assuming for simplicity that the potential follow-up exceeds i
intervals, wij¼0. The number with complete follow-up, nij
0,i s
Loss-adjusted survival of cervix cancer
S Sriamporn et al
109
British Journal of Cancer (2004) 91(1), 106–110 & 2004 Cancer Research UK
E
p
i
d
e
m
i
o
l
o
g
ygiven by
nij
0 ¼ nij   lij
To overcome the problems in estimation by multifactorial methods
caused by sparse numbers in the stratified approach, loss-adjusted
survival can also be estimated by logistic regression methods
(Breslow and Day, 1980).
The proportion dying with complete follow-up, qi
0, given the
prognostic factors xi,y,xk, is first estimated for patients not lost
to follow-up, nij
0, in the interval i:
qi
0 ¼
expðm0Þ
ð1 þ expðm0Þ
where mi
0 ¼ boi þ b1ix1i þ ::: þ bkixki,the hazard in interval i given
the prognostic factors. The proportion of deaths can be estimated
for each level of any prognostic variable xi adjusting for the
effect of the other prognostic variables. This is done for every
interval i.
The expected number of deaths among patients lost to follow-up
is then computed as d0
ij¼q0
ijlij, and the expected proportion of
deaths among all nij cases is
qij ¼
dij þ dij
nij
¼
Dij
nij
The procedure is repeated for the next interval (i¼iþ1) with
nðiþ1Þj
0 ¼ nij   dij   lðiþ1Þj and with l0
ðiþ1Þj ¼ lðiþ1Þj þ lij   d0
ij; and
with d0
ðiþ1Þj ¼ q0
ðiþ1Þjl0
ðiþ1Þjand for the other prognostic
strata.
Accumulating over prognostic strata will result in an annual
loss-adjusted rate:
qiðLossAdjustedÞ¼
P
j
Dij
P
j
nij
and the cumulative loss-adjusted (crude) survival rate is
piðLossAdjustedÞ¼ð 1   q1Þð1   q2Þ...ð1   qiÞ
If there are withdrawals (wij), the normal actuarial approxima-
tion is
qij ¼
Dij
nij   1
2wij
The approach corresponds to adjustment by stratification.
The process described for the stratified analysis will be applied
for dij
0, qi(LAR) and ultimately for Pi(LAR), by repeating the
estimation of qi(LAR) over the first i intervals.
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